Beam Therapeutics shares surged more than 12% in premarket trading

83
8
Favorite

Beam Therapeutics shares surged more than 12% in premarket trading

Tiger Newspress2022-01-10

Beam Therapeutics shares surged more than 12% in premarket trading.Gene editing is the next phase of genetic medicine, and another big step was just announced. Monday morning, Pfizer (ticker: PFE) unveiled a $1.3 billion partnership with Beam Therapeutics (BEAM) to develop three treatments for genetic disease in the next four years. They’ll use Beam’s leading-edge technology that makes precise corrections to typographical errors in our genes—a technology called “base editing”.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（8）

Success88
·2022-01-11
Ok
Reply
Like
Report
ANGG
·2022-01-10
Hope not worth much now with Fed tightening[Cry]
Reply
Like
Report
lost0star
·2022-01-10
Okay
Reply
2
Report
flamingdino
·2022-01-10
Ok
Reply
3
Report
koolgal
·2022-01-10
Pfizer and Beam Therapeutics are in partnership to develop new medical therapy and it is no wonder Beam Therapeutics share price rose 12%! Go Pfizer! 🚀🚀🚀🌙🌙🌙
Reply
15
Report
CYK1955
·2022-01-10
K
Reply
9
Report
kellggm
·2022-01-10
Like pls
Reply
12
Report
WW1012
·2022-01-10
Good
Reply
8
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1189975890?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-01-10 19:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189975890","market":"us","top_or_hot":-1,"title":"Beam Therapeutics shares surged more than 12% in premarket trading","media":"Tiger Newspress","content":"<html><head></head><body><p>Beam Therapeutics shares surged more than 12% in premarket trading.<img src=\"https://static.tigerbbs.com/df251b0e86938aeea230280e3a1c8757\" tg-width=\"708\" tg-height=\"597\" width=\"100%\" height=\"auto\"/>Gene editing is the next phase of genetic medicine, and another big step was just announced. Monday morning, Pfizer (ticker: PFE) unveiled a $1.3 billion partnership with Beam Therapeutics (BEAM) to develop three treatments for genetic disease in the next four years. They’ll use Beam’s leading-edge technology that makes precise corrections to typographical errors in our genes—a technology called “base editing”.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beam Therapeutics shares surged more than 12% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeam Therapeutics shares surged more than 12% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n2022-01-10 19:03 北京时间&nbsp;&nbsp;&nbsp;<strong>Tiger Newspress</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Beam Therapeutics shares surged more than 12% in premarket trading.Gene editing is the next phase of genetic medicine, and another big step was just announced. Monday morning, Pfizer (ticker: PFE) ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BEAM","symbol_name":"Beam Therapeutics, Inc.","start_time":0,"source_url":"","article_id":"1189975890","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189975890","pubTimestamp":1641812590,"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Beam Therapeutics shares surged more than 12% in premarket trading.Gene editing is the next phase of","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BEAM":"Beam Therapeutics, Inc."},"translate_title":"Beam Therapeutics股价在盘前交易中飙升超过12%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BEAM":0.9},"content_text":"Beam Therapeutics shares surged more than 12% in premarket trading.Gene editing is the next phase of genetic medicine, and another big step was just announced. Monday morning, Pfizer (ticker: PFE) unveiled a $1.3 billion partnership with Beam Therapeutics (BEAM) to develop three treatments for genetic disease in the next four years. They’ll use Beam’s leading-edge technology that makes precise corrections to typographical errors in our genes—a technology called “base editing”.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9006781207,"gmtCreate":1641852959376,"gmtModify":1676533653240,"author":{"id":"4101948424484190","authorId":"4101948424484190","authorIdStr":"4101948424484190","name":"Success88","avatar":"https://static.itradeup.com/news/4408e1a22d73e99adb53aa65dde8ad91","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":4,"crmLevelSwitch":0,"idStr":"4101948424484190"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006781207","repostId":1189975890,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9006451086,"gmtCreate":1641825505577,"gmtModify":1676533651235,"author":{"id":"3554804588226892","authorId":"3554804588226892","authorIdStr":"3554804588226892","name":"ANGG","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3554804588226892"},"htmlText":"Hope not worth much now with Fed tightening[Cry]&nbsp;","listText":"Hope not worth much now with Fed tightening[Cry]&nbsp;","text":"Hope not worth much now with Fed tightening[Cry]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006451086","repostId":1189975890,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9006410930,"gmtCreate":1641816015396,"gmtModify":1676533650107,"author":{"id":"3577931905567659","authorId":"3577931905567659","authorIdStr":"3577931905567659","name":"lost0star","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3577931905567659"},"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006410930","repostId":1189975890,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9006436273,"gmtCreate":1641814162842,"gmtModify":1676533650028,"author":{"id":"3570624615389043","authorId":"3570624615389043","authorIdStr":"3570624615389043","name":"flamingdino","avatar":"https://static.tigerbbs.com/c8effc5389a5f433a89c5f59c6b0462f","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3570624615389043"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006436273","repostId":1189975890,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9006431972,"gmtCreate":1641813371741,"gmtModify":1676533649967,"author":{"id":"3559581955535845","authorId":"3559581955535845","authorIdStr":"3559581955535845","name":"koolgal","avatar":"https://static.tigerbbs.com/c05274d88ffc0434623e57350c52c70a","vip":2,"hat":"https://static.tigerbbs.com/0a8758340a08196056f8bc1e54805193","crmLevel":6,"crmLevelSwitch":1,"idStr":"3559581955535845"},"htmlText":"Pfizer and Beam Therapeutics are&nbsp;in partnership to develop new medical therapy and it is no wonder Beam Therapeutics share price rose 12%! Go Pfizer! 🚀🚀🚀🌙🌙🌙","listText":"Pfizer and Beam Therapeutics are&nbsp;in partnership to develop new medical therapy and it is no wonder Beam Therapeutics share price rose 12%! Go Pfizer! 🚀🚀🚀🌙🌙🌙","text":"Pfizer and Beam Therapeutics are in partnership to develop new medical therapy and it is no wonder Beam Therapeutics share price rose 12%! Go Pfizer! 🚀🚀🚀🌙🌙🌙","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":15,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006431972","repostId":1189975890,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9006439230,"gmtCreate":1641812918029,"gmtModify":1676533649929,"author":{"id":"4088680907294400","authorId":"4088680907294400","authorIdStr":"4088680907294400","name":"CYK1955","avatar":"https://static.tigerbbs.com/679672f252a501703bd797c51e7c8b67","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4088680907294400"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006439230","repostId":1189975890,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9006439673,"gmtCreate":1641812892009,"gmtModify":1676533649921,"author":{"id":"4091242653201920","authorId":"4091242653201920","authorIdStr":"4091242653201920","name":"kellggm","avatar":"https://static.tigerbbs.com/9422af2f28cfb8bf300aed5fe1f942c9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4091242653201920"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006439673","repostId":1189975890,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9006439851,"gmtCreate":1641812890294,"gmtModify":1676533649921,"author":{"id":"3553224628095486","authorId":"3553224628095486","authorIdStr":"3553224628095486","name":"WW1012","avatar":"https://static.tigerbbs.com/f992cdfebad899a930707fdd9a236024","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3553224628095486"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006439851","repostId":1189975890,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":83,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}